17:36 EDT Roivant Sciences files $1.5B mixed securities shelf
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ROIV:
- Roivant Sciences price target raised to $16 from $14 at Goldman Sachs
- Immunovant announces $300M offering of common stock
- Unusually active option classes on open September 26th
- Roivant Announces Positive Initial IMVT-1402 Phase 1 SAD and 300 mg Subcutaneous MAD Results
- Roivant Announces Redemption Fair Market Value in Connection with Redemption of its Outstanding Warrants